Abstract:Background: Schizophrenia is a serious mental disorder with complicated biological mechanisms. Few studies explore the transcriptional features that are shared in brain tissue and peripheral blood. In the present study, we aimed to explore the biological pathways with similar expression patterns in both peripheral blood mononuclear cells (PBMCs) and brain tissues. Methods: The present study used transcriptomics technology to detect mRNA expression of PBMCs of 10 drug-naïve patients with schizophrenia and 20 healthy controls. Transcriptome data sets of brain tissue of patients with schizophrenia downloaded from public databases were also analyzed in our study. The biological pathways with similar expression patterns in the PBMCs and brain tissues were uncovered by differential expression analysis, weighted gene co-expression network analysis (WGCNA), and pathway analysis. Finally, the expression levels of differential expressed genes (DEGs) were validated by real-time fluorescence quantitative polymerase chain reaction (qPCR) in another 12 drug-naïve patients with schizophrenia and 12 healthy controls. Results: We identified 542 DEGs, 51 DEGs, 732 DEGs, and 104 DEGs in PBMCs, dorsolateral prefrontal cortex, anterior cingulate gyrus, and nucleus accumbent, respectively. Five DEG clusters were recognized as having similar gene expression patterns in PBMCs and brain tissues by WGCNA. The pathway analysis illustrates that these DEG clusters are mainly enriched in several biological pathways that are related to phospholipid metabolism, ribosome signal transduction, and mitochondrial oxidative phosphorylation. The differential significance of PLAAT3, PLAAT4, PLD2, RPS29, RPL30, COX7C, COX7A2, NDUFAF2 , and ATP5ME were confirmed by qPCR. Conclusions: This study finds that the pathways associated with phospholipid metabolism, ribosome signal transduction, and energy metabolism have similar expression patterns in PBMCs and brain tissues of patients with schizophrenia. Our results supply a novel insight for revealing the pathogenesis of schizophrenia and might offer a new approach to explore potential biological markers of peripheral blood in schizophrenia.

Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia.

Deregulatory miRNA-BDNF Network Inferred from Dynamic Expression Changes in Schizophrenia

Whole transcriptome analysis reveals dysregulation of molecular networks in schizophrenia

A Potential Immune-Related miRNAs Regulatory Network and Corresponding Diagnostic Efficacy in Schizophrenia

Converging evidence implicates the abnormal microRNA system in schizophrenia.

Transcriptomic Causal Networks identified patterns of differential gene regulation in human brain from Schizophrenia cases versus controls

Increased Variability Of Genomic Transcription In Schizophrenia

Transcriptomics Analysis Reveals Shared Pathways in Peripheral Blood Mononuclear Cells and Brain Tissues of Patients With Schizophrenia

A Potential Autophagy-Related Competing Endogenous RNA Network and Corresponding Diagnostic Efficacy in Schizophrenia

Systematic association analysis of microRNA machinery genes with schizophrenia informs further study

Transcriptomic analysis of postmortem brain identifies dysregulated splicing events in novel candidate genes for schizophrenia.

Mirna-Coordinated Schizophrenia Risk Network Cross-Talk with Cardiovascular Repair and Opposed Gliomagenesis

Altered expression of mRNA profiles in blood of early-onset schizophrenia

Brain transcriptional regulatory architecture and schizophrenia etiology converge between East Asian and European ancestral populations

Exploration of Positive and Negative Schizophrenia Symptom Heterogeneity and Establishment of Symptom-Related miRNA-mRNA Regulatory Network: Based on Transcriptome Sequencing Data

System biology approaches to identify hub genes linked with ECM organization and inflammatory signaling pathways in schizophrenia pathogenesis

Consistent Gene Signature of Schizophrenia Identified by a Novel Feature Selection Strategy from Comprehensive Sets of Transcriptomic Data

Associating Multimodal Neuroimaging Abnormalities with the Transcriptome and Neurotransmitter Signatures in Schizophrenia.

microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder

Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis

Path from schizophrenia genomics to biology: gene regulation and perturbation in neurons derived from induced pluripotent stem cells and genome editing